Lv1
50 积分 2023-10-24 加入
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
7天前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
7天前
已完结
Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment
19天前
已完结
Loss and enhancement of layer-selective signals in geniculostriate and corticotectal pathways of adult human amblyopia
1个月前
已完结
Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis
1个月前
已完结
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease
1个月前
已完结
Pevonedistat, a new partner for 5-azacitidine
3个月前
已关闭
Pevonedistat, a new partner for 5-azacitidine
3个月前
已关闭
Cancer incidence and mortality in China, 2022
3个月前
已完结
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease
4个月前
已完结
皖公网安备34019202002308
